What are the major opportunities in the Visceral Pain market? What are the strategies for the Visceral Pain market?

For detailed insights on the major opportunities and strategies in the Visceral Pain market, Read More

How does the Visceral Pain market relate to the overall economy and other similar markets?

For detailed insights on Visceral Pain's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Visceral Pain market growth? SWOT analysis of the Visceral Pain market.

For detailed insights on the key dynamics influencing the Visceral Pain market growth and SWOT analysis of the Visceral Pain industry, Read More

Visceral Pain Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Visceral Pain Market Report 2026

Name: Visceral Pain Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes), By Indications (Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Visceral Pain Market Overview

• Visceral Pain market size has reached to $14.82 billion in 2025

• Expected to grow to $19.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion

• Market Trend: Innovative NOP Receptor Agonists Advance Development Of Safer, Non-Addictive Pain Therapies

• North America was the largest region in 2025.

What Is Covered Under Visceral Pain Market?

Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.

The main types of visceral pain drug class are calcium channel blockers, nonsteroidal anti-inflammatories (NSAID), and others. Calcium channel blockers (CCBs) refer to a class of medications that primarily affect the movement of calcium ions into the cells of the heart and blood vessels. The various indications include interstitial cystitis, Crohn’s, irritable bowel, chronic prostatitis, and others. These are used by various end-users such as hospitals, homecare, specialty clinics, and others.

Visceral Pain Market Global Report 2026 Market Report bar graph

What Is The Visceral Pain Market Size and Share 2026?

The visceral pain market size has grown strongly in recent years. It will grow from $14.82 billion in 2025 to $15.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of gastrointestinal and pelvic disorders, wider use of NSAIDs and calcium channel blockers, improved clinical recognition of visceral pain conditions, expansion of hospital-based pain management services, availability of diversified drug classes.

What Is The Visceral Pain Market Growth Forecast?

The visceral pain market size is expected to see strong growth in the next few years. It will grow to $19.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for personalized pain therapies, rising focus on chronic pain management, expansion of precision medicine approaches, growing adoption of advanced diagnostic tools, increasing investments in non-opioid drug development. Major trends in the forecast period include increasing adoption of targeted pain management therapies, rising use of multimodal drug combinations, growing focus on non-opioid treatment options, expansion of personalized visceral pain management, enhanced emphasis on early diagnosis and intervention.

Book your 30 minutes free consultation with our research experts

Global Visceral Pain Market Segmentation

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

What Is The Driver Of The Visceral Pain Market?

The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in April 2024, according to the New England Journal of Medicinepublished in the New England Journal of Medicine, a UK-based weekly medical journal, over 53,600 clinicians were prescribing buprenorphine by December 2023. This represents an increase of 11,500 prescribers compared to December 2022. Therefore, the rising demand for analgesics is driving the growth of the visceral pain industry.

Key Players In The Global Visceral Pain Market

Major companies operating in the visceral pain market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Global Visceral Pain Market Trends and Insights

Major companies operating in the chronic pain market are focusing on conducting clinical trials to develop innovative products such as NOP receptor agonists to provide effective pain relief while potentially reducing the risks associated with opioid-based treatments. NOP receptor agonists are compounds that activate the nociceptin/orphanin FQ peptide receptor, which modulates pain signaling in the nervous system; they help by reducing chronic and visceral pain without causing the high risk of addiction or severe side effects typically associated with traditional opioids. For instance, in October 2024, Grünenthal GmbH, a Germany-based pharmaceutical company, initiated a first-in-human Phase I clinical trial enrolling 90 healthy participants to evaluate the safety, tolerability, and pharmacokinetics of its novel NOP receptor agonist. This study aims to assess the potential of the investigational compound to provide potent and safe pain relief across chronic pain conditions, offering a novel therapeutic approach to managing both somatic and visceral pain.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Visceral Pain Market?

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired the India manufacturing facility of Teva Pharmaceuticals for an undisclosed amount. As a result of the acquisition, Marksans gains a 47,597-square-meter facility, enabling it to double its production capacity in India from 8 billion units annually. This added capacity will support the production of tablets, hard and soft gel capsules, ointments, liquids, and creams. Teva Pharmaceuticals is an Israel-based provider of treatments for visceral pain.

Regional Outlook

North America was the largest region in the visceral pain market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Visceral Pain Market?

The visceral pain market consists of sales of opioids, anticonvulsants, gabapentin, and pregabalin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Visceral Pain Market Report 2026?

The visceral pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the visceral pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Visceral Pain Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$15.7 billion
Revenue Forecast In 2035	$19.6 billion
Growth Rate	CAGR of 5.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Indications, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Visceral Pain Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Visceral Pain Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Visceral Pain Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Visceral Pain Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Pain Management Therapies

4.2.2 Rising Use Of Multimodal Drug Combinations

4.2.3 Growing Focus On Non-Opioid Treatment Options

4.2.4 Expansion Of Personalized Visceral Pain Management

4.2.5 Enhanced Emphasis On Early Diagnosis And Intervention

5. Visceral Pain Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Pain Management Centers

5.4 Homecare Providers

5.5 Ambulatory Care Centers

6. Visceral Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Visceral Pain Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Visceral Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Visceral Pain Market Size, Comparisons And Growth Rate Analysis

7.3. Global Visceral Pain Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Visceral Pain Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Visceral Pain Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Visceral Pain Market Segmentation

9.1. Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

9.2. Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

9.3. Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End Users

9.4. Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dihydropyridines, Non-Dihydropyridines

9.5. Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Selective COX-2 Inhibitors, Non-Selective NSAIDs

9.6. Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

10. Visceral Pain Market Regional And Country Analysis

10.1. Global Visceral Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Visceral Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Visceral Pain Market

11.1. Asia-Pacific Visceral Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Visceral Pain Market

12.1. China Visceral Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Visceral Pain Market

13.1. India Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Visceral Pain Market

14.1. Japan Visceral Pain Market Overview

14.2. Japan Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Visceral Pain Market

15.1. Australia Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Visceral Pain Market

16.1. Indonesia Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Visceral Pain Market

17.1. South Korea Visceral Pain Market Overview

17.2. South Korea Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Visceral Pain Market

18.1. Taiwan Visceral Pain Market Overview

18.2. Taiwan Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Visceral Pain Market

19.1. South East Asia Visceral Pain Market Overview

19.2. South East Asia Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Visceral Pain Market

20.1. Western Europe Visceral Pain Market Overview

20.2. Western Europe Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Visceral Pain Market

21.1. UK Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Visceral Pain Market

22.1. Germany Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Visceral Pain Market

23.1. France Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Visceral Pain Market

24.1. Italy Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Visceral Pain Market

25.1. Spain Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Visceral Pain Market

26.1. Eastern Europe Visceral Pain Market Overview

26.2. Eastern Europe Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Visceral Pain Market

27.1. Russia Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Visceral Pain Market

28.1. North America Visceral Pain Market Overview

28.2. North America Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Visceral Pain Market

29.1. USA Visceral Pain Market Overview

29.2. USA Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Visceral Pain Market

30.1. Canada Visceral Pain Market Overview

30.2. Canada Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Visceral Pain Market

31.1. South America Visceral Pain Market Overview

31.2. South America Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Visceral Pain Market

32.1. Brazil Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Visceral Pain Market

33.1. Middle East Visceral Pain Market Overview

33.2. Middle East Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Visceral Pain Market

34.1. Africa Visceral Pain Market Overview

34.2. Africa Visceral Pain Market, Segmentation By Drug Class, Segmentation By Indications, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Visceral Pain Market Regulatory and Investment Landscape

36. Visceral Pain Market Competitive Landscape And Company Profiles

36.1. Visceral Pain Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Visceral Pain Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Visceral Pain Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Visceral Pain Market Other Major And Innovative Companies

Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH

38. Global Visceral Pain Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Visceral Pain Market

40. Visceral Pain Market High Potential Countries, Segments and Strategies

40.1 Visceral Pain Market In 2030 - Countries Offering Most New Opportunities

40.2 Visceral Pain Market In 2030 - Segments Offering Most New Opportunities

40.3 Visceral Pain Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Visceral Pain Market, Overview Of Key Products - Product Examples

Table 2: Global Visceral Pain Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Visceral Pain Market, Supply Chain Analysis

Table 4: Global Visceral Pain Market, Major Raw Material Providers

Table 5: Global Visceral Pain Market, Major Resource Providers

Table 6: Global Visceral Pain Market, Major Manufacturers (Suppliers)

Table 7: Global Visceral Pain Market, Major Distributors And Channel Partners

Table 8: Global Visceral Pain Market, Key Technologies & Future Trends

Table 9: Global Visceral Pain Market, Major Trends

Table 10: Global Visceral Pain Market, Major End Users

Table 11: Global Visceral Pain Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Visceral Pain Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Visceral Pain Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Visceral Pain Market - TAM, US$ Billion, 2025

Table 15: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Visceral Pain Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Visceral Pain Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: Johnson & Johnson Services Inc. Financial Performance

Table 99: F. Hoffmann-La Roche Ltd. Financial Performance

Table 100: Merck & Co.Inc. Financial Performance

Table 101: AbbVie Inc. Financial Performance

Table 102: Global Visceral Pain Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Visceral Pain Market, Competitive Dashboard

Table 104: Global Visceral Pain Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 106: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By Indications, 2025 – 2030

Table 107: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

Figure 1: Global Visceral Pain Market, Overview Of Key Products - Product Examples

Figure 2: Global Visceral Pain Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Visceral Pain Market, Supply Chain Analysis

Figure 4: Global Visceral Pain Market, Major Raw Material Providers

Figure 5: Global Visceral Pain Market, Major Resource Providers

Figure 6: Global Visceral Pain Market, Major Manufacturers (Suppliers)

Figure 7: Global Visceral Pain Market, Major Distributors And Channel Partners

Figure 8: Global Visceral Pain Market, Key Technologies & Future Trends

Figure 9: Global Visceral Pain Market, Major Trends

Figure 10: Global Visceral Pain Market, Major End Users

Figure 11: Global Visceral Pain Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Visceral Pain Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Visceral Pain Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Visceral Pain Market - TAM, US$ Billion, 2025

Figure 15: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Visceral Pain Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Visceral Pain Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: Johnson & Johnson Services Inc. Financial Performance

Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 100: Merck & Co.Inc. Financial Performance

Figure 101: AbbVie Inc. Financial Performance

Figure 102: Global Visceral Pain Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Visceral Pain Market, Competitive Dashboard

Figure 104: Global Visceral Pain Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 106: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By Indications, 2025 – 2030

Figure 107: Global, Visceral Pain Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Next-Gen Spasmodic Dysphonia Treatment : Market Forecast, Transformation, and Long-Term Trajectories

Specimen Validity Testing Growth Trajectory: Key Forecasts and Strategic Insights

Speech And Language Disorder Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Digital Diagnostics Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Automobile Remanufacturing Market Report 2026 - Global Outlook – By Type (Engine; Transmission; Starter; Generator; Other Types), By Manufacturer (Original Equipment Manufacturer (OEM) Remanufacturers; Independent Remanu...

Ostomy Devices Market Report 2026 - Global Outlook – By Product (Bags, Accessories), By System Type (One-Piece System, Two-Piece System), By Surgery Type (Colostomy, Urostomy, Ileostomy), By End Users (Ambulatory Surgica...

Emollients Market Report 2026 - Global Outlook – By Type (Esters, Fatty Alcohols, Fatty Acids, Ethers, Silicones, Other Types), By Form (Solid, Liquid), By Application (Skin Care, Hair Care, Other Applications), By End U...

Analgesics Market Report 2026 - Global Outlook – By Type (Non-opioids, Opioids ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores ), By Application (Internal Analgesics, External Analgesics )...

Military Infrastructure Market Report 2026 - Global Outlook – By Type (Harbor, Proving Ground, Range, Training Course), By Size (Small, Medium, Large), By Application (Army, Navy, Air Force) – Market Size, Trends, Strate...

Insurance Analytics Market Report 2026 - Global Outlook – By Component (Solution, Service), By Deployment Model (On-Premises, Cloud), By Enterprise Size (Large Enterprises, Small And Medium Enterprises (SMEs)) – Market S...

Frequently Asked Questions

How big is the Visceral Pain Market?

The Visceral Pain market was valued at $14.82 billion in 2025, increased to $15.7 billion in 2026, and is projected to reach $19.6 billion by 2030.

What is the Visceral Pain market growth?

The global Visceral Pain market is expected to grow at a CAGR of 5.7% from 2026 to 2035 to reach $19.6 billion by 2035.

Who are the key players in Visceral Pain market?

Some Key Players in the Visceral Pain market Include, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Ta

Major trend in this market includes: Innovative NOP Receptor Agonists Advance Development Of Safer, Non-Addictive Pain Therapies. For further insights on this market. request a sample here

North America was the largest region in the visceral pain market in 2025. The regions covered in the visceral pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Book your 30 minutes free consultation with our research experts

Contact Us